.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Accenture
Deloitte
Mallinckrodt
Cipla
Johnson and Johnson
Teva
McKesson
Novartis
Cerilliant

Generated: July 21, 2017

DrugPatentWatch Database Preview

Alfuzosin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for alfuzosin hydrochloride and what is the scope of alfuzosin hydrochloride patent protection?

Alfuzosin hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex Inc, Mylan, Wockhardt Ltd, Torrent Pharms, Teva Pharms, Sun Pharma Global, Aurobindo Pharma Ltd, Invagen Pharms, Concordia Pharms Inc, and Unichem Labs Ltd, and is included in ten NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Alfuzosin hydrochloride has fifty-one patent family members in thirty-eight countries.

There are nineteen drug master file entries for alfuzosin hydrochloride. Twenty-two suppliers are listed for this compound.

Summary for Generic Name: alfuzosin hydrochloride

Tradenames:2
Patents:2
Applicants:10
NDAs:10
Drug Master File Entries: see list19
Suppliers / Packagers: see list22
Bulk Api Vendors: see list44
Clinical Trials: see list2,282
Patent Applications: see list344
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:alfuzosin hydrochloride at DailyMed

Pharmacology for Ingredient: alfuzosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL079014-001Jul 18, 2011ABRXNoNo► Subscribe► Subscribe
Invagen Pharms
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL090284-001Jan 17, 2012ABRXNoNo► Subscribe► Subscribe
Sun Pharma Global
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL079057-001Jul 18, 2011ABRXNoNo► Subscribe► Subscribe
Apotex Inc
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL079013-001Jul 18, 2011ABRXNoNo► Subscribe► Subscribe
Concordia Pharms Inc
UROXATRAL
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL021287-001Jun 12, 2003ABRXYesYes6,149,940*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: alfuzosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc
UROXATRAL
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL021287-001Jun 12, 20034,661,491*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: alfuzosin hydrochloride

Country Document Number Estimated Expiration
Colombia4920217► Subscribe
Greece3036291► Subscribe
MexicoPA99001958► Subscribe
Cyprus2284► Subscribe
Iceland4964► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health
AstraZeneca
Queensland Health
Cipla
McKinsey
Accenture
Harvard Business School
Farmers Insurance
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot